Literature DB >> 8159385

Chyloperitoneum following treatment for advanced gynecologic malignancies.

J P Geisler1, R S Foster, G P Sutton.   

Abstract

BACKGROUND: Chyloperitoneum is an uncommon complication following retroperitoneal surgery. Blunt abdominal trauma, abdominal surgery, abdominal or pelvic radiation, cirrhosis, lymphoma, tuberculosis, and congenital defects of lacteal formation may also lead to chylous ascites. CASES: Two patients developed chylous ascites after treatment for gynecologic malignancies. One, who also received pelvic and abdominal radiation, developed chylous ascites 11 months after retroperitoneal lymph node dissection for advanced endometrial cancer. She was treated with a diet low in fat and high in medium-chain triglycerides, as well as with intravenous hyperalimentation. She had recurrences of chylous ascites, which responded to paracentesis and intravenous hyperalimentation. The second patient developed chylous ascites 2 months after retroperitoneal lymph node dissection for advanced fallopian tube cancer. She was treated with a medium-chain triglyceride diet, which resulted in resolution of her symptoms.
CONCLUSION: Chyloperitoneum is an uncommon complication following treatment for gynecologic malignancies. Our second case is the first reported in which retroperitoneal lymph node dissection for gynecologic malignancy resulted in chyloperitoneum. However, because gynecologic malignancies frequently metastasize to the periaortic lymph nodes, chylous ascites may be an important cause of morbidity following treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8159385

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

Review 1.  Treatment of chyloperitoneum after extended lymphatic dissection during duodenopancreatectomy.

Authors:  O Kollmar; M K Schilling; M W Büchler
Journal:  Int J Pancreatol       Date:  2000-02

2.  Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed: risk factors and management options.

Authors:  Mohammed Abu Hilal; David M Layfield; Francesco Di Fabio; Irantzu Arregui-Fresneda; Ioanna G Panagiotopoulou; Thomas H Armstrong; Neil W Pearce; Colin D Johnson
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.